The Nasdaq Stock Market ended the session with Catalyst Pharmaceuticals jumping 3.5% to $3.55 on Tuesday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market rose 0.45% to $12,576.50, after three sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Catalyst Pharmaceuticals today’s close was $3.55, 48.73% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company’s growth estimates for the present quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.55 at 16:18 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is higher than its 50-day moving average of $3.32 and under its 200-day moving average of $3.81.


Please enter your comment!
Please enter your name here